Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: A reappraisal
- 10 January 2003
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (1) , 12-20
- https://doi.org/10.1002/art.10738
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2Science, 2002
- Incidence of serious upper gastrointestinal bleeding/perforation in the general population:Journal of Clinical Epidemiology, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studiesBritish Journal of Clinical Pharmacology, 2001
- Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxenGut, 2001
- IndobufenDrugs & Aging, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Distinct roles of prostaglandin H synthases 1 and 2 in T-cell developmentJournal of Clinical Investigation, 1999
- Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarctionEuropean Heart Journal, 1993
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986